In total, 8/11 (73%) patients with ATLL were positive for SOX4, while expression of SOX4 was observed in 2/20 (10%) patients with PTCL-NOS (Figure 4; p < 0.001). This evidence concerns the gene SOX4 and mature T-cell and NK-cell non-Hodgkin lymphoma.